|
|
Reg No |
118 79 29952 00 |
:מספר
רשום |
|
Trade Name |
TAMIFLU CAPSULES 75 MG |
:שם
מסחרי אנגלית |
|
Trade Name Heb. |
טמיפלו 75 מ"ג |
:שם
מסחרי עברית |
|
Route of Admin |
PER OS |
צורת
מתן |
|
Dosage Form |
CAPSULES |
צורת
מינון |
|
Health
Basket |
No |
|
לא |
סל
בריאות |
|
Manufacturer |
HOFFMANN LA ROCHE LTD, SWITZERLAND |
שם
יצרן |
|
Reg Owner |
ROCHE PHARMACEUTICAL (ISRAEL) LTD |
שם
בעל רישום |
|
Appl.date |
03/2000 |
תאריך הגשה |
|
Reg Date |
05/2010 |
תוקף
רשיון מתאריך |
|
Exp Date |
05/2020
|
תוקף
רשיון עד תאריך |
|
CUS |
V |
מכס
|
|
|
|
Indication |
|
Treatment of uncomplicated acute illness due to influenza infection in adults patients and patients who weigh more than 40 kg who have been symptomatic for no more than 2 days. - Post exposure prevention in adults and patients who weight more the 40 kg following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. - The appropriate use of Tamiflu for prevention of influenza should be determined on a case by case basis by the circumstances and the population requiring protection. In exceptional situations (e.g. in case of a mismatch between the circulating and vaccine virus strains and a pandemic situation) seasonal prevention could be considered in adults patients and patients who weigh more than 40 kg.
|
| Active Component |
מרכיבים
פעילים |
|
|
Concentration /dosage |
Active ingredient
|
| 75 MG |
OSELTAMIVIR AS PHOSPHATE |
|
ATC |
| ATC4 |
class ATC4 |
ATC5 |
class ATC5 |
| J05AH |
NEURAMINIDASE INHIBITORS |
J05AH02 |
OSELTAMIVIR |
|
|
|
General sale
|
Barcod |
Prescription drug
|
Shelf life |
Quantity in packaging
|
Packaging form
|
|
| לא |
|
כן |
חדשים 84 |
10 X CAPSULES |
BLISTER PVC/PE/PVDC |
|
|
Manufacture site |
אתר יצור |
|
| Produced |
Manufacture site address |
Manufacture site |
|
packing
|
WURMISWEG 232, CH-4303, KAISERAUSGT, SWITZERLAND |
HOFFMANN LA ROCHE LTD |
|
bulk
|
GRENZACHERSTRASSE 124, CH-4070 BASEL , SWITZERLAND |
HOFFMANN LA ROCHE LTD, SWITZERLAND |
|
|
|
